167 related articles for article (PubMed ID: 4399498)
1. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
Mazurkiewicz-Kwilecki IM; Romagnoli A
J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
[No Abstract] [Full Text] [Related]
2. Effect of beta-adrenergic blocking compounds on tissue catecholamine levels.
Klinge EA
Eur J Pharmacol; 1971 Apr; 14(2):124-9. PubMed ID: 4151170
[No Abstract] [Full Text] [Related]
3. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
Khanna NK
Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
[No Abstract] [Full Text] [Related]
4. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
Range H; Bischoff M; Siess M
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
[No Abstract] [Full Text] [Related]
5. Cardiac toxicity of -lytic drugs.
Roba J
Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
Brunner H; Hedwall PR; Meier M
Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
[No Abstract] [Full Text] [Related]
7. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
Gilfrich HJ; Rahn KH; Nicolescu RF
Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
[No Abstract] [Full Text] [Related]
8. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
Harry JD; Kappagoda CT; Linden RJ; Snow HM
Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
[No Abstract] [Full Text] [Related]
9. Selective metabolic and cardiovascular beta receptor antagonism in the rat.
Stanton HC
Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):246-58. PubMed ID: 4401080
[No Abstract] [Full Text] [Related]
10. Mechanism of anti-inflammatory activity of -adrenoceptor blocking agents.
Bhalla TN; Sinha JN; Tangri KK; Bhargava KP
Eur J Pharmacol; 1972 Dec; 20(3):366-8. PubMed ID: 4404943
[No Abstract] [Full Text] [Related]
11. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.
Alexandre JM; Menard J; Chevillard C; Schmitt H
Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344
[No Abstract] [Full Text] [Related]
12. Comparison of beta-adrenergic blocking effect of DCI, methoxamine, propranolol, MJ 1999, H 56-28, LB 46 and I.C.I. 50 172 on the chronotropic response to isoprenaline.
Okuda K; Chiba S; Taira N; Hashimoto K
Jpn J Pharmacol; 1970 Jun; 20(2):294-304. PubMed ID: 4393949
[No Abstract] [Full Text] [Related]
13. Beta-blocking drugs and human platelet aggregation in vitro.
Gibelli A; Montanari C; Bellani D; Mandelli V; Sacchetti G
Experientia; 1973 Feb; 29(2):186-7. PubMed ID: 4144249
[No Abstract] [Full Text] [Related]
14. Potentiation of bronchomotor responses by beta adrenergic antagonists.
Diamond L
J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
[No Abstract] [Full Text] [Related]
15. Effect of propranolol upon the hemoglobin-oxygen dissociation curve.
Pendleton RG; Newman DJ; Sherman SS; Brann EG; Maya WE
J Pharmacol Exp Ther; 1972 Mar; 180(3):647-56. PubMed ID: 4401159
[No Abstract] [Full Text] [Related]
16. Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man.
Fuccella LM; Reban J; Bassini F; Lattes E; Mandelli V
Eur J Clin Pharmacol; 1971 Dec; 4(1):12-7. PubMed ID: 4402874
[No Abstract] [Full Text] [Related]
17. An experimental study of the beta-receptor blocking agents on the cardiac performance in dogs.
Singh N; Srivastava RK; Kulshrestha VK; Sinha JN; Kohli RP; Bhargava KP
Jpn J Pharmacol; 1970 Dec; 20(4):467-72. PubMed ID: 4395619
[No Abstract] [Full Text] [Related]
18. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
Nakanishi M; Imamura H; Nakamura T; Kimura T
Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
[No Abstract] [Full Text] [Related]
19. New beta-adrenergic blocking agents. Cyclopropylphenyl derivatives.
Boissier JR; Ratouis R; Dumont C; Derible PH; Lavaux JP
J Med Chem; 1970 Sep; 13(5):971-3. PubMed ID: 4394057
[No Abstract] [Full Text] [Related]
20. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
Nayler WG; Tay J
J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
